DE602007013796D1 - Ausstossflüssigkeit und ausstossverfahren - Google Patents

Ausstossflüssigkeit und ausstossverfahren

Info

Publication number
DE602007013796D1
DE602007013796D1 DE602007013796T DE602007013796T DE602007013796D1 DE 602007013796 D1 DE602007013796 D1 DE 602007013796D1 DE 602007013796 T DE602007013796 T DE 602007013796T DE 602007013796 T DE602007013796 T DE 602007013796T DE 602007013796 D1 DE602007013796 D1 DE 602007013796D1
Authority
DE
Germany
Prior art keywords
exhaust liquid
compound
effluent process
group
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602007013796T
Other languages
English (en)
Inventor
Yohei Masada
Masaru Sugita
Hideki Kaneko
Naoko Sakurada
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Canon Inc
Original Assignee
Canon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Canon Inc filed Critical Canon Inc
Publication of DE602007013796D1 publication Critical patent/DE602007013796D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B65CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65DCONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D83/00Containers or packages with special means for dispensing contents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/001Particle size control
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/02Inhalators with activated or ionised fluids, e.g. electrohydrodynamic [EHD] or electrostatic devices; Ozone-inhalators with radioactive tagged particles
    • A61M15/025Bubble jet droplet ejection devices
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183Amino acids, e.g. glycine, EDTA or aspartame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Pulmonology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Otolaryngology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mechanical Engineering (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Particle Formation And Scattering Control In Inkjet Printers (AREA)
  • Ink Jet Recording Methods And Recording Media Thereof (AREA)
  • Application Of Or Painting With Fluid Materials (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Ink Jet (AREA)
  • Peptides Or Proteins (AREA)
  • Inks, Pencil-Leads, Or Crayons (AREA)
  • Treating Waste Gases (AREA)
DE602007013796T 2006-12-04 2007-11-09 Ausstossflüssigkeit und ausstossverfahren Active DE602007013796D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2006327031A JP4777225B2 (ja) 2006-12-04 2006-12-04 吐出用液体及び吐出方法
PCT/JP2007/072238 WO2008069012A2 (en) 2006-12-04 2007-11-09 Ejection liquid and ejection method

Publications (1)

Publication Number Publication Date
DE602007013796D1 true DE602007013796D1 (de) 2011-05-19

Family

ID=39343526

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602007013796T Active DE602007013796D1 (de) 2006-12-04 2007-11-09 Ausstossflüssigkeit und ausstossverfahren

Country Status (11)

Country Link
US (2) US20100069290A1 (de)
EP (1) EP2091513B1 (de)
JP (1) JP4777225B2 (de)
KR (1) KR20090086279A (de)
CN (1) CN101547684B (de)
AT (1) ATE504289T1 (de)
AU (1) AU2007330137A1 (de)
CA (1) CA2671634C (de)
DE (1) DE602007013796D1 (de)
RU (1) RU2420303C2 (de)
WO (1) WO2008069012A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4784789B2 (ja) * 2009-06-29 2011-10-05 セイコーエプソン株式会社 吐出用液体及び生体試料の吐出方法
JP5605760B2 (ja) * 2010-01-18 2014-10-15 セイコーエプソン株式会社 吐出用液体、生体試料の吐出方法、及び化合物
WO2012118236A1 (ja) * 2011-03-03 2012-09-07 帝人株式会社 繊維成形体

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991012799A1 (en) * 1990-02-28 1991-09-05 The Upjohn Company Use of 3-guanidinopropionic acid in the treatment and prevention of metabolic disorders
US5723496A (en) * 1991-03-05 1998-03-03 The Regents Of University Of California Method for prevention and treatment of harmful effects of intracellular acidosis
US6072075A (en) * 1997-05-22 2000-06-06 The Regents Of The University Of California Guanidinylation reagents
US6767892B1 (en) * 1997-11-07 2004-07-27 Chrion Corporation Compositions providing for increased IGF-I solubility
JP4147234B2 (ja) * 2004-09-27 2008-09-10 キヤノン株式会社 吐出用液体、吐出方法、カートリッジ及び吐出装置
US7594507B2 (en) * 2001-01-16 2009-09-29 Hewlett-Packard Development Company, L.P. Thermal generation of droplets for aerosol
EP1248108B1 (de) * 2001-03-29 2011-08-31 Canon Kabushiki Kaisha Verfahren zum Zellscreening und dafür geeignete Substrata
ES2268044T3 (es) 2001-05-21 2007-03-16 Injet Digital Aerosols Limited Composiciones para la administracion de proteinas por la via pulmonar.
KR20060028658A (ko) * 2001-11-22 2006-03-30 캐논 가부시끼가이샤 액체 토출 헤드
US7726303B2 (en) * 2003-02-25 2010-06-01 Hewlett-Packard Development Company, L.P. Controlled medicament ejection
JP4533044B2 (ja) * 2003-08-27 2010-08-25 キヤノン株式会社 センサ
US20060079673A1 (en) * 2004-08-02 2006-04-13 Paul Glidden Polynucleotides encoding tRNA synthetase fragments and uses thereof
US7659987B2 (en) * 2004-09-16 2010-02-09 Canon Kabushiki Kaisha Device and method for acquiring information on objective substance to be detected by detecting a change of wavelength characteristics on the optical transmittance
JP4147235B2 (ja) * 2004-09-27 2008-09-10 キヤノン株式会社 吐出用液体、吐出方法、液滴化方法、液体吐出カートリッジ及び吐出装置
GB0503434D0 (en) * 2005-02-18 2005-03-30 Senexis Ltd Amyloid-binding peptides, analogues and uses thereof
JP4646669B2 (ja) * 2005-03-30 2011-03-09 キヤノン株式会社 吐出用液体、吐出方法、液滴化方法、カートリッジ及び吐出装置
JP4689340B2 (ja) * 2005-05-02 2011-05-25 キヤノン株式会社 吐出用液体医薬組成物
PL1909601T3 (pl) * 2005-08-02 2014-03-31 Alzchem Ag Ciekły preparat zawierający składnik na bazie kwasu guanidynooctowego
US8028554B2 (en) * 2006-09-03 2011-10-04 Essence Security International Ltd. Electronic cylinder lock apparatus and methods

Also Published As

Publication number Publication date
US20130068784A1 (en) 2013-03-21
CN101547684A (zh) 2009-09-30
RU2009125531A (ru) 2011-01-20
JP4777225B2 (ja) 2011-09-21
EP2091513A2 (de) 2009-08-26
JP2008137967A (ja) 2008-06-19
CA2671634A1 (en) 2008-06-12
RU2420303C2 (ru) 2011-06-10
KR20090086279A (ko) 2009-08-11
US20100069290A1 (en) 2010-03-18
ATE504289T1 (de) 2011-04-15
EP2091513B1 (de) 2011-04-06
CN101547684B (zh) 2012-12-12
AU2007330137A1 (en) 2008-06-12
CA2671634C (en) 2012-03-13
WO2008069012A2 (en) 2008-06-12
WO2008069012A3 (en) 2008-08-07

Similar Documents

Publication Publication Date Title
DK1893587T3 (da) Fremgangsmåde til fremstilling af dihydroquinazoliner
HRP20220455T1 (hr) Modificirane aminokiseline koje sadrže azid grupu
CY1113684T1 (el) Anti-mikρobiaka πεπτιδια που περιλαμβανουν μια αργινινη (arginine)- kai/ή λυσινη (lysine)- που περιεχουν υποκινητη
EA200901609A1 (ru) Амиды пиразолкарбоновой кислоты, применимые в качестве микробиоцидов
GT200800154A (es) N-sulfonilacion selectiva de alcoholes 2-amino trifluoroalquilo sustituidos
EA200870217A1 (ru) 4-арил-2-аминопиримидины или 4-арил-2-аминоалкилпиримидины в качестве модуляторов jak-2 и содержащие их фармацевтические композиции
CY1112185T1 (el) Σταθερο συμπλοκο δραστικων ουσιων απο αλατα των o-ακετυλοσαλικυλικων οξεων με βασικα αμινοξεα και γλυκινη
AU2014290206B2 (en) Specific targeting of RNA expanded repeat sequences
EA200870302A1 (ru) 1,3-диоксанкарбоновые кислоты
CY1118173T1 (el) 5-[(3,3,3-τριφθορο-2-υδροξυ-1-αρυλπροπυλ)αμινο]-1h-κινολιν-2-ονες, μια διεργασια για την παραγωγη τους και η χρηση τους ως αντι-φλεγμονωδων παραγοντων
BRPI0514741A (pt) derivados de hexahidro-pirazino[1, 2-a]pirimidina-4, 7-diona substituìdos por aminoácidos
BRPI0508969A (pt) compostos orgánicos
AR057909A1 (es) Proceso para preparar montelukast y compuestos relacionados, que utiliza un compuesto intermediario derivado de un ester sulfonico.
ATE485261T1 (de) Salicylsäurederivate
BR112014021993A2 (pt) detecção da variação de nucleotídeo em sequência de ácido nucleico alvo através de ensaio de clivagem e extensão de pto
NO20081207L (no) Isoquinolines as IGF-1R inhibitors
DE602007013796D1 (de) Ausstossflüssigkeit und ausstossverfahren
EA200701852A1 (ru) Производные аминокислот
AR075097A1 (es) Sales y formas polimorficas cristalinas de [4-(6-fluoro-7-metilamino-2,4-dioxo-1,4-dihidro-2h-quinazolin-3-il)-fenil]-5-cloro-tiofen-2-il-sulfonil urea, composiciones farmaceuticas que las contiene, metodo para prepararlas y uso de las mismas en el tratamiento de enfermedades cardiovasculares asocia
EA200900780A1 (ru) Аналоги эпотилона, модифицированные в положениях c12-c13, как противораковые лекарственные средства
EA201070194A1 (ru) Стабильная жидкая фармацевтическая композиция на основе тразодона
AR047461A1 (es) Formacion, purificacion y uso de n-formilolanzapina
UY30952A1 (es) Polimorfos de s,s-dioxido del acido 7-[3-cloro-6,11-dihidro-6-metildibenzo[c,f][1,2]tiazepin-11-ilamino]heptanoico y métodos para su preparacion y uso
DE502007006487D1 (de) Lagerstabile wässrige Zusammensetzungen, umfassend eine Magnesiumverbindung und L-Carnitin
WO2010066253A8 (en) Selective inhibitors of excitatory amino acid transporter subtype 1 (eaat1 /glast)